Pro-inflammatory cytokine TNF-α is highly expressed in patients with IBD and plays a crucial role in the initiation, prolongation, and persistence of intestinal inflammation, and anti-TNF-α antibody therapy has been shown to be highly effective in the treatment of CD and UC (40, 42, 43). This evidence concerns the gene TNF and inflammatory bowel disease.